Christina Ackermann

Christina Ackermann has over 20 years of experience as General Counsel and Senior Executive in the pharmaceutical industry. She currently serves as Executive Vice President, General Counsel and Head of Commercial Operations at Bausch Health Companies, Inc. She joined Bausch Health in 2016 as Executive Vice President, General Counsel responsible for the company’s worldwide legal affairs, compliance, global security and enterprise risk management, and was named Head of Commercial Operations in June 2020. Prior to that, Christina was part of the Novartis group of companies for 14 years. She served as Senior Vice President, General Counsel for Alcon, as Global Head, Legal and General Counsel for Sandoz, as well as Head Legal General Medicine and Head, Legal Technical Operations and Ophthalmics for Novartis Pharmaceuticals. Prior to Novartis, Christina served in various Associate General Counsel roles at Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities, and mergers & acquisitions. Christina attended York University, Toronto, Canada, for her undergraduate studies focusing first on Fine Arts, and then concentrating on mathematics and political sciences. She obtained her Law degree (an LL.B.) from Queen’s University, Kingston, Canada, and earned her Post Graduate Diploma in EC Competition Law from King’s College, University of London, United Kingdom.